Mirati Therapeutics, Inc. - stock earnings
Stock symbol MRTX is outdated, potentially delisted? Maybe it is available on other exchange?
MRTX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / -2.5883000000 | - | - / 23.2 million | - |
MRTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -202.5 million USD | 934000 USD |
| 2022Q3 | -173.6 million USD | 5.4 million USD |
| 2022Q2 | -176.4 million USD | 5.4 million USD |
| 2022Q1 | -188.4 million USD | 709000 USD |
| 2021Q4 | -199.6 million USD | 299000 USD |
| 2021Q3 | -80.1 million USD | 71.8 million USD |
| 2021Q2 | -166.4 million USD | ? USD |
| 2021Q1 | -135.7 million USD | ? USD |
| 2020Q4 | -101.1 million USD | 1.7 million USD |
| 2020Q3 | -87.3 million USD | 11.4 million USD |
MRTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -740.9 million USD | 12.4 million USD |
| 2021 | -581.8 million USD | 72.1 million USD |
| 2020 | -357.9 million USD | 13.4 million USD |
| 2019 | -213.3 million USD | 3.3 million USD |
| 2018 | -98.4 million USD | 12.9 million USD |
| 2017 | -70.4 million USD | ? USD |
MRTX
Price: $58.70
52 week price:
Earnings Per Share: -12.18 USD
P/E Ratio: -4.71
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 933700
Ebitda: -16.6 millionMarket Capitalization: 4.2 billion